RF
GILD icon

RHS Financial’s Gilead Sciences GILD Stock Holding History

RHS Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$622K Sell
4,466
-16
-0.4% -$2.24K 0.29% 66
2025
Q4 		$550K Buy
4,482
+205
+5% +$24.9K 0.27% 66
2025
Q3 		$475K Buy
4,277
+2,169
+103% +$247K 0.25% 69
2025
Q2 		$234K Buy
+2,108
New +$224K 0.13% 116

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

RHS Financial's GILD Position: Q1 2026 in Review

RHS Financial reduced its Gilead Sciences (GILD) stake by 0.36% in Q1 2026, selling an estimated $2.24K and leaving 4,466 shares worth $622K. The position accounts for 0.29% of the portfolio, ranked #66.

RHS Financial first reported a position in GILD in Q2 2025 and has held it in 4 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • RHS Financial held 4,466 shares of Gilead Sciences worth $622K as of Q1 2026.
  • RHS Financial sold 16 Gilead Sciences shares in Q1 2026, an estimated $2.24K.
  • Gilead Sciences made up 0.29% of RHS Financial's portfolio in Q1 2026, its #66 holding.
  • RHS Financial first reported a position in Gilead Sciences in Q2 2025 and has held it in 4 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on RHS Financial's 13F filing for Q1 2026, filed 28 Apr 2026.